11+ mon, 1+ week ago  (544+ words) Out-of-pocket expenses for bowel preparation may limit access to colonoscopy, potentially delaying diagnosis and treatment, according to a study published in Gastroenterology. "To have a test where you can identify a cancer before it starts is so gratifying," Eric D. Shah,…...

7+ hour, 14+ min ago  (447+ words) NEW ORLEANS " Once-weekly survodutide was linked with substantial reductions in body weight and liver fat content among individuals with obesity and metabolic dysfunction-associated steatotic liver disease. The phase 3 SYNCHRONIZE-1 trial, simultaneously published in The New England Journal of Medicine, assessed…...

15+ hour, 45+ min ago  (372+ words) NEW ORLEANS — New data from three phase 2b studies demonstrate substantial weight loss with berobenatide, an ultralong-acting GLP-1 receptor agonist, in people with obesity or overweight, with and without type 2 diabetes. Both weekly and monthly dosing was feasible and well…...

11+ hour, 45+ min ago  (388+ words) NEW ORLEANS — Use of automated insulin delivery during hospitalization may improve glycemic outcomes for adults with insulin-treated diabetes, according to data presented at the American Diabetes Association Scientific Sessions. In the AIDING randomized controlled trial, hospitalized adults with diabetes…...

17+ hour, 47+ min ago  (115+ words) NEW ORLEANS — In adults with insulin-treated type 2 diabetes, an automated insulin delivery system conferred lower Hb A1c and improved time in range at 13 weeks, researchers reported at the American Diabetes Association Scientific Sessions. As Healio previously reported, the system (twiist,…...

11+ mon, 3+ week ago  (302+ words) ORLANDO " Both very low and very high levels of vitamin D appear to increase risk for falls and fractures, a speaker said at the American Association of Clinical Endocrinology Annual Scientific and Clinical Conference. The large VITAL, Vi DA and…...

1+ day, 12+ hour ago  (1338+ words) NEW ORLEANS "A triple receptor agonist provided weight loss for adults with obesity, with or without type 2 diabetes, to an extent not seen with previous pharmacotherapy options, according to data from two phase 3 trials. During a symposium at the American…...

1+ day, 9+ hour ago  (110+ words) NEW ORLEANS — Continuous glucose monitoring may have a role for adults with type 2 diabetes who are not using insulin, according to results from the CONNECT trial. “ We know that CGM has been shown to be effective for individuals…...

1+ day, 18+ hour ago  (578+ words) NEW ORLEANS — A once-daily GLP-1/GIP dual agonist reduced Hb A1c and body weight at 16 weeks among adults with type 1 diabetes, according to findings from a phase 2 trial presented at the American Diabetes Association Scientific Sessions. Acmopatide (Roche), formerly known…...

1+ day, 18+ hour ago  (100+ words) NEW ORLEANS — A next-generation automated insulin delivery algorithm was tied to improved glycemic outcomes compared with a currently available system, according to data presented at the American Diabetes Association Scientific Sessions. In the STRIVE trial, researchers assessed glycemic outcomes,…...